Financial Incentives for Smoking Treatment

NYU Langone Health182 enrolled

Overview

The investigators plan to compare the impact of two approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life among a diverse population of patients at the Manhattan campus of the VA New York Harbor Healthcare System, which serves a critical safety-net role for urban veterans. During hospitalization, all smokers will receive usual care. Patients will be randomized to one of two arms: financial incentives plus usual care vs. usual care alone, which includes referral to the state Quitline. All patients enrolled in the study will be offered nicotine replacement therapy. The investigators will conduct follow-up assessments at 2 weeks, 2 months, 6 months and 12 months after discharge. The primary study outcome is smoking abstinence at 6-month follow-up, verified by salivary/urinary cotinine.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

182

Conditions

Smoking Smoking, Tobacco Tobacco Use Disorder

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. age ≥ 18 years, 2. smoked tobacco during the prior 30 days, 3. have an active U.S. phone number and address, 4. can provide consent in English and 5. are in at least the contemplative stage of change for quitting smoking, as assessed by a single measure, readiness to quit Exclusion Criteria: 1. use only smokeless tobacco, 2. are pregnant or breastfeeding, 3. are discharged to an institution (e.g., nursing home, long-term care facility), 4. are unable to provide informed consent, or do not have cognitive ability to enroll or participate in the study

Outcomes

Primary Outcomes

Smoking abstinence assessed by self-reported and biochemically verified by salivary cotinine

Assessed by self-report questionnaire, and biochemically verified by salivary cotinine

Time frame: 6 months

Secondary Outcomes

Smoking abstinence assessed by self-report

Assessed by self-report questionnaire

Time frame: 6 months

Use of evidence based treatment (e.g. counseling and smoking cessation medications) assessed by discharge prescriptions, Quitline records, receipts, letters and/or self-report

Assessed by discharge prescriptions, Quitline records, receipts, letters and/or self-report

Time frame: 2 weeks and 2 months

Quality of life as measured by the EQ5-D and VR-12

As measured by the EQ5-D and VR-12

Time frame: 6 months

Short term return on investment of using financial incentives to promote smoking cessation (Cost analysis)

Cost analysis involving hospital utilization data, electronic health records and patient-reported healthcare utilization

Time frame: 12 months

Long term return on investment of using financial incentives to promote smoking cessation (Cost analysis)

Cost analysis involving hospital utilization data, electronic health records and patient-reported healthcare utilization

Time frame: 3 years

Financial Incentives for Smoking Treatment

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes